Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer

Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer

Background. The role of neoadjuvant chemotherapy (NACT) in luminal HER2-negative breast cancer (BC) remains highly controversial due to the lack of reliable predictors of drug therapy efficacy.Objective: to evaluate the effectiveness of NACT in patients with aggressive luminal HER2-negative BC and t...

Full description

Saved in:
Bibliographic Details
Main Authors: D.  A. Morozov, I. V. Kolyadina, I. V. Poddubnaya, I.  P. Ganshina, S. V. Khokhlova, V. V. Kometova, V. V. Rodionov
Format: Article
Language:Russian
Published: ABV-press 2022-01-01
Series:Опухоли женской репродуктивной системы
Subjects:
breast cancer
luminal her2-negative subtype
predictor factors for reaching pcr
residual pathomorphological stage of yptn
residual tumor burden according to the rcb system
tils
erlow tumor expression
her low tumor expression
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/894
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ojrs.abvpress.ru/ojrs/article/view/894

Similar Items